Pluto Bioinformatics

GSE80239: EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq]

Bulk RNA sequencing

We reported here the gene expression profiles that were mediated upon the treatment of EZH2 inhibitor in two hormone-refractory prostate cancer cell lines: the sensitive, AR-positive abl cells and the insensitive, AR-null DU145 cells. SOURCE: Kexin Xu (kxuthscsa@gmail.com) - UT Health Science Center at San Antonio